NEUROSENSE THERAPEUTICS LTD C/W
NRSNW
Last
$0.01
Day
-27.3%
1y
-93.7%
5y
-98.6%
52w
-98.6%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.05
EMA 50
0.09
EMA 200
0.23
20d high
-84.0%
5y high
-99.3%
5y range
0th
Positions held
Your positionsNRSNW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-35
Hold
avoid
Signal
Strong Sell
Target
$0.04
Stop
$-0.01
Stop distance
169.4%
Target vs last
+177.8%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -0.04 | Beta | 1.64 | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -21.7% | ROA | -2.5% | Debt / equity | — |
| Current ratio | 0.31 | Free cash flow | -$3.87M | Analyst recommendation | none | Mean target | — |
| 52w high | $0.04 | 52w low | $0.01 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$11.1M | -$10.2M | -$10.1M | -$10.5M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$11.1M | -$9.9M | -$12.0M | -$10.6M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsNRSNW · daily-70.6% over 11 sessions
Close EMA21 EMA50 EMA200